SurModics, Inc. is a leading provider of drug delivery and surface modification technologies to the healthcare industry. Our technologies are utilized by our customers to either alter the characteristics of the surfaces of devices and biological materials or to enable drug delivery from coatings, implants or injected microparticles. SurModics partners with many of the world’s leading and emerging medical device, pharmaceutical and life sciences companies to develop and commercialize innovative diagnostic and therapeutic products designed to improve patient outcomes.

Through our technologies, our healthcare industry customers develop improved products or products with new functionality. Our core offerings include: drug delivery technologies (coatings, microparticles, and implants)  and  surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities. Our strategy is to build on our technical leadership in the field of drug delivery and surface modification technologies and products, enabling us to strengthen our position as a leading edge product development partner to the healthcare industry.

Our key market focus areas include cardiovascular disease, ophthalmology, pharmaceutical, in vitro diagnostics, and additional growing clinical markets.

SurModics' Advantages:

• Demonstrated leadership and expertise in the development of drug delivery and surface modification technologies
• Unique opportunity to drive convergence of drugs and medical devices
• Partner of choice for the world's leading and emerging growth medical device, pharmaceutical, and biotechnology companies
• Broad portfolio of proprietary platforms enables development, manufacture, and commercialization of breakthrough products
• Experienced technical staff with expertise in chemical engineering, biomedical engineering, bioanalytical chemistry, organic synthesis, protein chemistry, cell biology, enzyme technology, microbiology, genomics, immunoassay development, process development, and advanced surface characterization
• Strong balance sheet with consistent record of growth, profitability and effective capital allocation
• Proven clinical trial manufacturing capabilities
• Flexible business model with support throughout development and commercialization
• Company focused on core values of customer partnership, innovation, integrity, entrepreneurship and responsibility